Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Presse Medicale (Paris, France : 1983)
|
August 14, 2012
[Short-term clinical effects of periprocedural statin therapy]
Pierre Ambrosi
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 18, 2020
Comment on "Epidemiological and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China" by Ren et al
Pierre Ambrosi
Lancet (London, England)
|
September 15, 2009
Aspirin in the primary prevention of vascular disease
Pierre Ambrosi
Presse Medicale (Paris, France : 1983)
|
January 16, 2010
[Letter on the article: "Which lipid profiles and how to interpret in patients with coronary heart disease?"]
Pierre Ambrosi
Clinical Transplantation
|
September 9, 2025
Answer to the Comments of H. Daungsupawong et al. About the Study Entitled Persistence of a High Seroconversion Rate 3.2 ± 0.13 Years After Last COVID-19 Vaccination in Heart Transplant Recipients
Robin Arcani, Pierre Ambrosi
Journal of Cardiac Failure
|
June 1, 2011
Human serum albumin in the clinical syndrome of heart failure
Stephane Arques, Pierre Ambrosi
Lancet (London, England)
|
May 6, 2023
Unanswered questions from the IRONMAN trial
Pierre Ambrosi, Gilbert Habib
Clinical Transplantation
|
May 24, 2025
Persistence of a High Seroconversion Rate 3.2 ± 0.13 Years After Last COVID-19 Vaccination in Heart Transplant Recipients
Robin Arcani, Pierre Ambrosi
Presse Medicale (Paris, France : 1983)
|
April 24, 2012
[The cardiologist and immunosuppressive therapy]
Pierre Ambrosi, Pierre Lafforgue
Transplantation
|
June 9, 2026
Response to "Chronic Rejection Series: Heart Cardiac Allograft Vasculopathy"
Grégoire Stolpe, Pierre Ambrosi
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Presse Medicale (Paris, France : 1983)
|
August 14, 2012
[Short-term clinical effects of periprocedural statin therapy]
Pierre Ambrosi
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 18, 2020
Comment on "Epidemiological and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China" by Ren et al
Pierre Ambrosi
Lancet (London, England)
|
September 15, 2009
Aspirin in the primary prevention of vascular disease
Pierre Ambrosi
Presse Medicale (Paris, France : 1983)
|
January 16, 2010
[Letter on the article: "Which lipid profiles and how to interpret in patients with coronary heart disease?"]
Pierre Ambrosi
Clinical Transplantation
|
September 9, 2025
Answer to the Comments of H. Daungsupawong et al. About the Study Entitled Persistence of a High Seroconversion Rate 3.2 ± 0.13 Years After Last COVID-19 Vaccination in Heart Transplant Recipients
Robin Arcani, Pierre Ambrosi
Journal of Cardiac Failure
|
June 1, 2011
Human serum albumin in the clinical syndrome of heart failure
Stephane Arques, Pierre Ambrosi
Lancet (London, England)
|
May 6, 2023
Unanswered questions from the IRONMAN trial
Pierre Ambrosi, Gilbert Habib
Clinical Transplantation
|
May 24, 2025
Persistence of a High Seroconversion Rate 3.2 ± 0.13 Years After Last COVID-19 Vaccination in Heart Transplant Recipients
Robin Arcani, Pierre Ambrosi
Presse Medicale (Paris, France : 1983)
|
April 24, 2012
[The cardiologist and immunosuppressive therapy]
Pierre Ambrosi, Pierre Lafforgue
Transplantation
|
June 9, 2026
Response to "Chronic Rejection Series: Heart Cardiac Allograft Vasculopathy"
Grégoire Stolpe, Pierre Ambrosi
Page
of 8